ProShare Advisors’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,342
Closed -$45K 2122
2022
Q1
$45K Sell
2,342
-558
-19% -$10.7K ﹤0.01% 2119
2021
Q4
$52K Buy
2,900
+90
+3% +$1.61K ﹤0.01% 2281
2021
Q3
$104K Sell
2,810
-480
-15% -$17.8K ﹤0.01% 1910
2021
Q2
$196K Buy
3,290
+414
+14% +$24.7K ﹤0.01% 2152
2021
Q1
$193K Buy
2,876
+809
+39% +$54.3K ﹤0.01% 2053
2020
Q4
$125K Buy
2,067
+610
+42% +$36.9K ﹤0.01% 1954
2020
Q3
$115K Sell
1,457
-53
-4% -$4.18K ﹤0.01% 1513
2020
Q2
$94K Buy
1,510
+504
+50% +$31.4K ﹤0.01% 1574
2020
Q1
$53K Sell
1,006
-767
-43% -$40.4K ﹤0.01% 1116
2019
Q4
$215K Buy
1,773
+18
+1% +$2.18K ﹤0.01% 1542
2019
Q3
$318K Sell
1,755
-44
-2% -$7.97K ﹤0.01% 1196
2019
Q2
$234K Sell
1,799
-241
-12% -$31.3K ﹤0.01% 1350
2019
Q1
$497K Buy
2,040
+42
+2% +$10.2K ﹤0.01% 1023
2018
Q4
$381K Sell
1,998
-369
-16% -$70.4K ﹤0.01% 1042
2018
Q3
$776K Buy
2,367
+104
+5% +$34.1K 0.01% 930
2018
Q2
$706K Sell
2,263
-162
-7% -$50.5K ﹤0.01% 970
2018
Q1
$590K Sell
2,425
-399
-14% -$97.1K ﹤0.01% 1036
2017
Q4
$853K Buy
2,824
+2,609
+1,213% +$788K 0.01% 898
2017
Q3
$57K Sell
215
-61
-22% -$16.2K ﹤0.01% 1340
2017
Q2
$73K Sell
276
-70
-20% -$18.5K ﹤0.01% 1408
2017
Q1
$124K Sell
346
-136
-28% -$48.7K ﹤0.01% 1500
2016
Q4
$139K Buy
482
+186
+63% +$53.6K ﹤0.01% 1654
2016
Q3
$101K Sell
296
-71
-19% -$24.2K ﹤0.01% 1418
2016
Q2
$156K Buy
367
+15
+4% +$6.38K ﹤0.01% 1468
2016
Q1
$113K Sell
352
-18
-5% -$5.78K ﹤0.01% 1503
2015
Q4
$192K Buy
370
+128
+53% +$66.4K ﹤0.01% 1553
2015
Q3
$71K Sell
242
-79
-25% -$23.2K ﹤0.01% 1401
2015
Q2
$126K Sell
321
-138
-30% -$54.2K ﹤0.01% 1567
2015
Q1
$139K Sell
459
-4
-0.9% -$1.21K ﹤0.01% 1771
2014
Q4
$103K Sell
463
-393
-46% -$87.4K ﹤0.01% 1837
2014
Q3
$199K Sell
856
-124
-13% -$28.8K ﹤0.01% 1977
2014
Q2
$217K Sell
980
-767
-44% -$170K ﹤0.01% 2121
2014
Q1
$551K Buy
+1,747
New +$551K 0.01% 1794
2013
Q4
Sell
-986
Closed -$144K 1850
2013
Q3
$144K Buy
+986
New +$144K ﹤0.01% 2307